搜索临床试验以:氢可酮/对乙酰氨基酚缓释
总计840个结果
-
Johnson & Johnson Pharmaceutical Research & Development...Grünenthal GmbH终止
-
University of California, San FranciscoThe CARESTAR Foundation终止
-
US Department of Veterans Affairs完全的
-
University of Alabama at BirminghamHeron Therapeutics撤销
-
Yale UniversityUniversity of South Florida; New York University; Icahn School of Medicine at Mount Sinai; Shire完全的
-
McNeil Consumer & Specialty Pharmaceuticals, a...完全的
-
Andrew A HerringUniversity of California, Los Angeles; Oregon Health and Science University未知
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)暂停
-
Oregon Health and Science UniversityNational Institute on Drug Abuse (NIDA)完全的
-
UCB Pharma完全的
-
Johnson & Johnson Pharmaceutical Research & Development...完全的
-
Soleno Therapeutics, Inc.尚未招聘SH2B1 缺乏性肥胖 | 与 PCSK1 突变(rs6232 变体)相关的肥胖 | SIM1 缺乏症 肥胖症
-
NYU Langone HealthNational Institute on Alcohol Abuse and Alcoholism (NIAAA)完全的
-
Luye Pharma Group Ltd.完全的
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA); Alkermes, Inc.完全的
-
Rhodes Pharmaceuticals, L.P.未知
-
McNeil Consumer & Specialty Pharmaceuticals, a...完全的注意力缺陷多动障碍
-
National Cancer Institute (NCI)终止IVA 期口腔鳞状细胞癌 AJCC v6 和 v7 | IVA 期口咽鳞状细胞癌 AJCC v7 | IVB 期口腔鳞状细胞癌 AJCC v6 和 v7 | IVB 期口咽鳞状细胞癌 AJCC v7 | III 期口腔鳞状细胞癌 AJCC v6 和 v7 | III 期口咽鳞状细胞癌 AJCC v7 | II 期口腔鳞状细胞癌 AJCC v6 和 v7 | I 期口咽鳞状细胞癌 AJCC v6 和 v7 | II 期口咽鳞状细胞癌 AJCC v6 和 v7 | 口腔肿瘤 | 口咽肿瘤 | 0 期口腔鳞状细胞癌 AJCC v6 和 v7 | 0 期口咽鳞状细胞癌 AJCC v6 和 v7 | I 期口腔鳞状细胞癌 AJCC v6 和 v7美国
-
Shire完全的注意力缺陷多动障碍 (ADHD)西班牙, 德国, 乌克兰, 法国, 意大利, 奥地利, 比利时, 爱尔兰, 荷兰, 波兰, 罗马尼亚, 瑞典, 英国
-
Duke UniversityAlkermes, Inc.; Laura and John Arnold Foundation; FHR (Fellowship Health Resources, Inc.); Drug...完全的
-
Merck Sharp & Dohme LLC终止